Logo image of BX

BLACKSTONE INC (BX) Stock Fundamental Analysis

NYSE:BX - New York Stock Exchange, Inc. - US09260D1072 - Common Stock - Currency: USD

130.39  +1.01 (+0.78%)

After market: 130.4 +0.01 (+0.01%)

Fundamental Rating

5

Taking everything into account, BX scores 5 out of 10 in our fundamental rating. BX was compared to 228 industry peers in the Capital Markets industry. BX scores excellent on profitability, but there are concerns on its financial health. BX is not overvalued while it is showing excellent growth. This is an interesting combination.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

BX had positive earnings in the past year.
BX had a positive operating cash flow in the past year.
BX had positive earnings in each of the past 5 years.
BX had a positive operating cash flow in each of the past 5 years.
BX Yearly Net Income VS EBIT VS OCF VS FCFBX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

1.2 Ratios

BX has a Return On Assets of 6.39%. This is in the better half of the industry: BX outperforms 74.89% of its industry peers.
BX's Return On Equity of 33.81% is amongst the best of the industry. BX outperforms 96.92% of its industry peers.
BX has a better Return On Invested Capital (18.55%) than 95.59% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BX is significantly above the industry average of 7.06%.
The 3 year average ROIC (12.81%) for BX is below the current ROIC(18.55%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.39%
ROE 33.81%
ROIC 18.55%
ROA(3y)4.65%
ROA(5y)6.43%
ROE(3y)25.68%
ROE(5y)30.98%
ROIC(3y)12.81%
ROIC(5y)17.48%
BX Yearly ROA, ROE, ROICBX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

1.3 Margins

With a Profit Margin value of 20.99%, BX perfoms like the industry average, outperforming 58.15% of the companies in the same industry.
In the last couple of years the Profit Margin of BX has declined.
The Operating Margin of BX (51.81%) is better than 88.99% of its industry peers.
In the last couple of years the Operating Margin of BX has remained more or less at the same level.
Industry RankSector Rank
OM 51.81%
PM (TTM) 20.99%
GM N/A
OM growth 3Y-4.19%
OM growth 5Y1.25%
PM growth 3Y-6.82%
PM growth 5Y-5.56%
GM growth 3YN/A
GM growth 5YN/A
BX Yearly Profit, Operating, Gross MarginsBX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

3

2. Health

2.1 Basic Checks

The number of shares outstanding for BX has been increased compared to 1 year ago.
BX has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, BX has an improved debt to assets ratio.
BX Yearly Shares OutstandingBX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
BX Yearly Total Debt VS Total AssetsBX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.2 Solvency

An Altman-Z score of 3.43 indicates that BX is not in any danger for bankruptcy at the moment.
BX's Altman-Z score of 3.43 is fine compared to the rest of the industry. BX outperforms 78.85% of its industry peers.
BX has a debt to FCF ratio of 3.31. This is a good value and a sign of high solvency as BX would need 3.31 years to pay back of all of its debts.
The Debt to FCF ratio of BX (3.31) is better than 75.77% of its industry peers.
A Debt/Equity ratio of 1.38 is on the high side and indicates that BX has dependencies on debt financing.
BX has a worse Debt to Equity ratio (1.38) than 66.08% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.38
Debt/FCF 3.31
Altman-Z 3.43
ROIC/WACCN/A
WACCN/A
BX Yearly LT Debt VS Equity VS FCFBX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

BX has a Current Ratio of 0.63. This is a bad value and indicates that BX is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.63, BX is not doing good in the industry: 69.60% of the companies in the same industry are doing better.
BX has a Quick Ratio of 0.63. This is a bad value and indicates that BX is not financially healthy enough and could expect problems in meeting its short term obligations.
BX has a worse Quick ratio (0.63) than 69.60% of its industry peers.
Industry RankSector Rank
Current Ratio 0.63
Quick Ratio 0.63
BX Yearly Current Assets VS Current LiabilitesBX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 19.95% over the past year.
BX shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 14.97% yearly.
Looking at the last year, BX shows a very strong growth in Revenue. The Revenue has grown by 64.90%.
BX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.51% yearly.
EPS 1Y (TTM)19.95%
EPS 3Y-0.92%
EPS 5Y14.97%
EPS Q2Q%11.22%
Revenue 1Y (TTM)64.9%
Revenue growth 3Y-16.32%
Revenue growth 5Y12.51%
Sales Q2Q%8.41%

3.2 Future

BX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.46% yearly.
Based on estimates for the next years, BX will show a quite strong growth in Revenue. The Revenue will grow by 15.92% on average per year.
EPS Next Y25.62%
EPS Next 2Y24.44%
EPS Next 3Y23.06%
EPS Next 5Y14.46%
Revenue Next Year15.68%
Revenue Next 2Y20.81%
Revenue Next 3Y20.83%
Revenue Next 5Y15.92%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BX Yearly Revenue VS EstimatesBX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B 25B
BX Yearly EPS VS EstimatesBX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8 10

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 27.45 indicates a quite expensive valuation of BX.
70.93% of the companies in the same industry are cheaper than BX, based on the Price/Earnings ratio.
BX is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 28.29, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 18.15, which indicates a rather expensive current valuation of BX.
BX's Price/Forward Earnings is on the same level as the industry average.
BX is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 21.08, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 27.45
Fwd PE 18.15
BX Price Earnings VS Forward Price EarningsBX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BX indicates a somewhat cheap valuation: BX is cheaper than 66.52% of the companies listed in the same industry.
BX's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 46.46
EV/EBITDA 24.39
BX Per share dataBX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

BX's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
BX has a very decent profitability rating, which may justify a higher PE ratio.
BX's earnings are expected to grow with 23.06% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.07
PEG (5Y)1.83
EPS Next 2Y24.44%
EPS Next 3Y23.06%

5

5. Dividend

5.1 Amount

BX has a Yearly Dividend Yield of 3.05%. Purely for dividend investing, there may be better candidates out there.
In the last 3 months the price of BX has falen by -27.54%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
Compared to an average industry Dividend Yield of 8.65, BX has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.52, BX pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.05%

5.2 History

The dividend of BX is nicely growing with an annual growth rate of 11.16%!
BX has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of BX decreased recently.
Dividend Growth(5Y)11.16%
Div Incr Years1
Div Non Decr Years1
BX Yearly Dividends per shareBX Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

159.34% of the earnings are spent on dividend by BX. This is not a sustainable payout ratio.
BX's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP159.34%
EPS Next 2Y24.44%
EPS Next 3Y23.06%
BX Yearly Income VS Free CF VS DividendBX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B
BX Dividend Payout.BX Dividend Payout, showing the Payout Ratio.BX Dividend Payout.PayoutRetained Earnings

BLACKSTONE INC

NYSE:BX (4/17/2025, 8:05:14 PM)

After market: 130.4 +0.01 (+0.01%)

130.39

+1.01 (+0.78%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)04-17 2025-04-17/bmo
Earnings (Next)07-16 2025-07-16/amc
Inst Owners70.58%
Inst Owner Change-0.02%
Ins Owners0.77%
Ins Owner Change4.05%
Market Cap158.90B
Analysts74
Price Target189.66 (45.46%)
Short Float %1.27%
Short Ratio2.43
Dividend
Industry RankSector Rank
Dividend Yield 3.05%
Yearly Dividend6.1
Dividend Growth(5Y)11.16%
DP159.34%
Div Incr Years1
Div Non Decr Years1
Ex-Date02-10 2025-02-10 (1.44)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.47%
Min EPS beat(2)6.51%
Max EPS beat(2)12.43%
EPS beat(4)2
Avg EPS beat(4)3.08%
Min EPS beat(4)-5.35%
Max EPS beat(4)12.43%
EPS beat(8)3
Avg EPS beat(8)1.56%
EPS beat(12)7
Avg EPS beat(12)5.69%
EPS beat(16)11
Avg EPS beat(16)9.46%
Revenue beat(2)1
Avg Revenue beat(2)1.5%
Min Revenue beat(2)-1.86%
Max Revenue beat(2)4.86%
Revenue beat(4)1
Avg Revenue beat(4)-1.02%
Min Revenue beat(4)-6.69%
Max Revenue beat(4)4.86%
Revenue beat(8)1
Avg Revenue beat(8)-9.03%
Revenue beat(12)2
Avg Revenue beat(12)-13.18%
Revenue beat(16)6
Avg Revenue beat(16)31.02%
PT rev (1m)-1.16%
PT rev (3m)3.85%
EPS NQ rev (1m)-6.35%
EPS NQ rev (3m)-14.49%
EPS NY rev (1m)-0.52%
EPS NY rev (3m)-3.18%
Revenue NQ rev (1m)-4.15%
Revenue NQ rev (3m)-17.45%
Revenue NY rev (1m)-5.63%
Revenue NY rev (3m)-10.34%
Valuation
Industry RankSector Rank
PE 27.45
Fwd PE 18.15
P/S 12.01
P/FCF 46.46
P/OCF 45.64
P/B 19.35
P/tB 25.81
EV/EBITDA 24.39
EPS(TTM)4.75
EY3.64%
EPS(NY)7.18
Fwd EY5.51%
FCF(TTM)2.81
FCFY2.15%
OCF(TTM)2.86
OCFY2.19%
SpS10.86
BVpS6.74
TBVpS5.05
PEG (NY)1.07
PEG (5Y)1.83
Profitability
Industry RankSector Rank
ROA 6.39%
ROE 33.81%
ROCE 22.24%
ROIC 18.55%
ROICexc 19.96%
ROICexgc 21.71%
OM 51.81%
PM (TTM) 20.99%
GM N/A
FCFM 25.85%
ROA(3y)4.65%
ROA(5y)6.43%
ROE(3y)25.68%
ROE(5y)30.98%
ROIC(3y)12.81%
ROIC(5y)17.48%
ROICexc(3y)14.24%
ROICexc(5y)19.2%
ROICexgc(3y)15.53%
ROICexgc(5y)21.12%
ROCE(3y)15.37%
ROCE(5y)21.01%
ROICexcg growth 3Y-21.19%
ROICexcg growth 5Y9.44%
ROICexc growth 3Y-21.05%
ROICexc growth 5Y9.86%
OM growth 3Y-4.19%
OM growth 5Y1.25%
PM growth 3Y-6.82%
PM growth 5Y-5.56%
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 1.38
Debt/FCF 3.31
Debt/EBITDA 1.64
Cap/Depr 170.75%
Cap/Sales 0.46%
Interest Coverage 16.83
Cash Conversion 50.53%
Profit Quality 123.19%
Current Ratio 0.63
Quick Ratio 0.63
Altman-Z 3.43
F-Score8
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)360.42%
Cap/Depr(5y)264.86%
Cap/Sales(3y)2.01%
Cap/Sales(5y)1.63%
Profit Quality(3y)249.28%
Profit Quality(5y)197.86%
High Growth Momentum
Growth
EPS 1Y (TTM)19.95%
EPS 3Y-0.92%
EPS 5Y14.97%
EPS Q2Q%11.22%
EPS Next Y25.62%
EPS Next 2Y24.44%
EPS Next 3Y23.06%
EPS Next 5Y14.46%
Revenue 1Y (TTM)64.9%
Revenue growth 3Y-16.32%
Revenue growth 5Y12.51%
Sales Q2Q%8.41%
Revenue Next Year15.68%
Revenue Next 2Y20.81%
Revenue Next 3Y20.83%
Revenue Next 5Y15.92%
EBIT growth 1Y97.33%
EBIT growth 3Y-19.82%
EBIT growth 5Y13.91%
EBIT Next Year24.73%
EBIT Next 3Y18.9%
EBIT Next 5Y6.22%
FCF growth 1Y-10.76%
FCF growth 3Y-4.46%
FCF growth 5Y12.44%
OCF growth 1Y-14.18%
OCF growth 3Y-4.41%
OCF growth 5Y12.14%